nam W. kim PH.d.

IMG_7853.JPG

Sholeh jAHANFARD

sHAHRAM gHOLAMI m.d.

Chief Executive Officer & Chief Technology Officer

Co-Founder
 

Nam is a seasoned scientist and executive with over 25 years of experience in developing and commercializing novel diagnostics tests at several cutting-edge biotechnology companies including  Geron, and diaDexus where he was responsible for the development of novel diagnostic and prognostic markers for cancer and cardiovascular diseases. 

President & Chief Operating Officer

 

Co-Founder

Sholeh is a clinical diagnostic expert with over 35 years of clinical diagnostics and life-science industry including  Kaiser Permanente, LifeScan (a Johnson & Johnson Company), DiaSorin, Incell Dx and Enzo LifeSciences. She has launched several novel tests both in the U.S. and internationally and managed the sales and marketing activities for ENZO LifeScience in Europe. 

Chief Medical Officer

Shahram is an internationally recognized urologist in the field of minimally invasive laparoscopic and robotic surgery and cystoscopy.  He is a practicing clinician with a renowned urology clinic located in the heart of silicon valley and affiliated with Good Samaritan Hospital and Stanford University.

Our story

At KDx Diagnostics, we believe in the advancement of bladder cancer recognition. Ever since our establishment in 2016, we have worked endlessly to achieve the highest sensitivity and specificity test. With the creation of our URO17(TM) kit, we have not only achieved such an inexpensive and non-invasive test, but also one that is simpler to use for the patient with results that are more accurate than ever before. We hope with the induction of the URO17(TM), we can strive for quicker recognition and response to the dangers of cancer and help out patients achieve a peaceful and care-free life..

Clinical Advisor/Collaborator
 

Kenneth Shroyer, M.D., Ph.D. - Stony Brook Medicine
Luisa Escobar-Hoyos, M.D., Ph.D. - Stony Brook Medicine
Sima Porten, M.D., MPH – UCSF
Nikhil Vasdev, MBBS, MRCS, ChM, FRCS – Lister Hospital

Consultants & Advisors
 

Dx Market/Business:
Doug Sweet – Former VP Marketing Agilent, Roche, Syva & Mol Devices
Vladimir Ostioich– Co-founder, Abaxis Inc.
Melya Crameri-Hughes – Ventec Partners

 

FDA Regulatory:
Mark Sarno – CEO Vision Biotechnology
Erika B. Ammirati - Regulatory Consulting